DOXORUBICIN (DXR) AND 4'-EPI-DOXORUBICIN (4EDXR) - CLINICAL-EXPERIENCE AND PHARMACOKINETICS

被引:0
作者
MARTONI, A
DIMARCO, AR
CAMAGGI, CM
STROCCHI, E
FRUET, F
MARRARO, D
GIOVANNINI, M
TOMASI, L
PACCIARINI, MA
PANNUTI, F
机构
[1] UNIV BOLOGNA,INST ORGAN CHEM,I-40126 BOLOGNA,ITALY
[2] FARMITALIA CARLO ERBA,MILAN,ITALY
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:767 / 774
页数:8
相关论文
共 10 条
[1]   ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY [J].
BLUM, RH ;
CARTER, SK .
ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :249-259
[2]  
BONFANTE V, 1979, CANCER TREAT REP, V63, P915
[3]  
CAMAGGI CM, 1982, CANCER TREAT REP, V66, P1819
[4]  
CASAZZA AM, 1978, 10TH P INT C CHEM ZU, V2, P1257
[5]  
LEGHA SS, 1982, CANCER, V49, P1962
[6]  
MARTONI A, 1981, CHEMIOTERAPIA ONCOLO, V5, P201
[7]  
MARTONI A, 1983, CANCER TREAT REP
[8]  
MINOW RA, 1978, CANCER TREAT REP, V62, P931
[9]  
PANNUTI F, 1980, CHEMIOTERAPIA ONCOLO, V4, P102
[10]   SAFE AND EFFECTIVE 2-HOUR OUTPATIENT REGIMEN OF HYDRATION AND DIURESIS FOR THE ADMINISTRATION OF CIS-DIAMMINEDICHLOROPLATINUM-(II) [J].
VOGL, SE ;
ZARAVINOS, T ;
KAPLAN, BH ;
WOLLNER, D .
EUROPEAN JOURNAL OF CANCER, 1981, 17 (03) :345-350